Navigation Links
Ash Stevens Inc. Named One of 'Michigan 50 Companies to Watch'
Date:4/21/2008

DETROIT, April 21 /PRNewswire/ -- Ash Stevens Inc. (ASI) has been recognized as one of the "Michigan 50 Companies to Watch," and will be honored at an awards ceremony during the third annual Michigan Celebrates Small Business event, Thursday, April 24, 2008 at 6 p.m. in Lansing, Mich.

Headquartered in Detroit Michigan, ASI is an established contract pharmaceutical manufacturing company that develops, registers and commercially manufactures Active Pharmaceutical Ingredients. With more than 45 years of custom drug manufacturing experience, ASI has emerged as a premier contract research organization for developing highly potent anticancer agents.

ASI's success in the industry stems from a focus on science with a commitment to quality and regulatory compliance. Today, the company holds 11 drug approvals, three of which were approved in less than two years.

ASI has invested more than $15 million in its manufacturing facility, located in Riverview, Mich., over the past five years. These improvements have expanded the company's capabilities while integrating new technology creating a safe, effective product development process. In addition, ASI has diversified its customer base while growing science-related jobs in Michigan.

"We are honored to receive this award and are proud to be working to grow employment and advance the pharmaceutical industry in Michigan," said Dr. Stephen Munk, president and CEO of Ash Stevens. "This award underscores our commitment to bettering the human condition by developing and manufacturing products that make a real difference in the lives of seriously ill people."

Founded in 1962 to service the Federal Government's chemical research needs, ASI has a long-standing research arrangement with the National Cancer Institute. ASI has more than 50 employees and holds a variety of patents covering topics including medicinal agents and manufacturing processes. For more information, visit our Web site at '/>"/>

SOURCE Ash Stevens Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
2. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
3. The USC Stevens Institute for Innovation Opens Shop on USC Health Sciences Campus
4. Stevens researchers provide new information about mass spectrometry
5. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
6. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
7. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
8. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
9. Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest
10. Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University
11. Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Sciences Inaugural Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... December 17, 2014 This report ... Quartz Tubing industry. For an overview analysis, the ... application, industry chain structure, industry overview, policy analysis, ... tubing industry has witnessed rapid development with ... of acquisitions. This report mentions quartz tubing upstream ...
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 Audacity, ... activation agency and member of the Huntsworth Health Group, ... to its executive team. In her role, Gonzales will ... , “We are incredibly honored to welcome a talent ... Chief and CEO, Gaëtan Fraikin. “She is a proven ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary commercial focus on ... been granted a Type C meeting with the U.S. ... will be held in February 2015.  During this meeting ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce ... V19 with PVM technology , is now available. ... measurement tool continuously captures high-resolution images under a ... automatically prepares a report pairing the most relevant ... changes. This compelling blend of high resolution images ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2
... August 28 XTL Biopharmaceuticals,Ltd. (NASDAQ: XTLB ... in the acquisition, development and commercialization of,therapeutics for ... and hepatitis C, today announced that issuances of,American ... bank,The Bank of New York, will be processed ...
... for,Lifesaving Cures revealed today a consequence of the ... by opponents of embryonic stem,cell research: It is ... exclude Missourians with common chromosomal abnormalities like Down,Klinefelter ... In their blind rush to put their ...
... 2 (DRC) announced,today the purchase of 25% of ... for $92.5M. DRC will also provide a $15M,milestone ... be met.,PEG-INTRON (peginterferon alpha-2b), is approved for the ... Schering-Plough Corporation (SGP). Speaking on behalf of ...
Cached Biology Technology:Processing Fees on ADRs to be Waived for two Months 2Processing Fees on ADRs to be Waived for two Months 3New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human 2Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN) 2
(Date:11/18/2014)... BOSTON , Nov. 17, 2014   ... HealthCare and EMC collaborate to develop The Partners ... , The Partners Data Lake will allow ... to improve diagnostics, treatment and the lives of ... support research and clinical activities across the Partners ...
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
(Date:11/12/2014)... 2014 Crossmatch™, a leading provider of biometric ... fingerprint readers have been deployed throughout Montparnasse Pasteleria, ... Mexico . The bakery chain implemented the Crossmatch ... caused by employees clocking in for each other. ... Montparnasse relied on paper timecards and a mechanical time ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
... The Scripps Research Institute have found evidence in laboratory ... recognize methamphetamine and boost tolerance to the drug through ... human studies, could help explain why chronic users go ... as speed. The study could lead to new treatments ...
... "dead zone" area of the Gulf of Mexico ?a region ... huge marine life losses ?has appeared much earlier this year, ... marine life more adversely than normal, researchers are reporting. , ... at Galveston, Louisiana State University and NASA recently surveyed the ...
... little follow-up on open access publishing and the ... The final National Institutes of Health (NIH) rule on ... of federal research dollars and a missed opportunity to ... to a group of the nation's leading not-for-profit medical ...
Cached Biology News:Chemists identify immune system mechanism for methamphetamine binges 2Chemists identify immune system mechanism for methamphetamine binges 3Dead zone area in Gulf could be increasing, researchers say 2Not-for-profit publishers call NIH public access rule a missed opportunity 2Not-for-profit publishers call NIH public access rule a missed opportunity 3
... FHS-LVF, and the CVD-Diffuse We've combined ... Filters to create the world's first notch ... adjustable bandpass. Each filter features an excellent ... These filters -- with interference coatings ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Ms anti-Cyclophilin D...
Protein Kinase D2 Immunogen: Human protein kinase D2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: